Evaluation of Efficacy and Safety of Anti-acne Spot Oil in participants suffering from Acne Vulgaris- An open label, non-comparative, interventional, prospective, clinical study. - NI

amaskar Ayurved Private Limited0 个研究点目标入组 30 人开始时间: 待定最近更新: 2024年6月24日

试验速览

暂无简介。

•1.Subjects suffering from acne vulgaris [mild and moderate as per Global Acne Grading System (GAGS)] as diagnosed by physician or dermatologist
•2.Subjects willing to follow study instructions given by the investigator

•1.Subjects with known pre-existing systemic disease necessitating long-term medications.
•2.Subjects with known current endocrinal disorders.
•3.Subjects taking treatment for menstrual disorders
•4.Subjects having systemic treatment for acne vulgaris.
•5.Subjects on any other investigational products within 1 month prior to randomization;
•6.Subjects with known current tuberculosis, HIV, ischemic heart disease, cancer, kidney failure.
•7.Pregnant and lactating women
•8.Known hypersensitivity to any of the ingredients of Anti-acne Spot Oil
•9.Other conditions, which in the opinion of the investigators, make patient unsuitable for enrolment or could interfere with his/her participation in, and completion of the study

发起方

amaskar Ayurved Private Limited